SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'SCN'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1BDW_A_DVAA6_0 (GRAMICIDIN A) |
3v48 | PUTATIVEAMINOACRYLATEHYDROLASE RUTD (Escherichiacoli) | 3 / 3 | ALA A 139VAL A 141TRP A 140 | NoneNoneSCN A 269 (-4.4A) | 0.77A | 1bdwA-3v48A:undetectable1bdwB-3v48A:undetectable | 1bdwA-3v48A:6.991bdwB-3v48A:6.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1BDW_A_DVAA6_0 (GRAMICIDIN A) |
3v48 | PUTATIVEAMINOACRYLATEHYDROLASE RUTD (Escherichiacoli) | 3 / 3 | ALA A 143VAL A 141TRP A 140 | NoneNoneSCN A 269 (-4.4A) | 0.89A | 1bdwA-3v48A:undetectable1bdwB-3v48A:undetectable | 1bdwA-3v48A:6.991bdwB-3v48A:6.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DZM_A_BZMA600_0 (ODORANT-BINDINGPROTEIN) |
3tl2 | MALATE DEHYDROGENASE (Bacillusanthracis) | 4 / 8 | ILE A 119MET A 241VAL A 127LEU A 276 | NoneNoneSCN A 314 (-4.8A)None | 0.89A | 1dzmA-3tl2A:undetectable | 1dzmA-3tl2A:24.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EKJ_A_ACTA3001_0 (BETA-CARBONICANHYDRASE) |
2a5v | CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)(CARBONICDEHYDRATASE) (Mycobacteriumtuberculosis) | 5 / 8 | CYH A 51ASP A 53HIS A 104CYH A 107GLY A 108 | ZN A 401 ( 2.3A)SCN A 501 (-4.0A) ZN A 401 ( 3.3A) ZN A 401 ( 2.3A)SCN A 501 (-4.2A) | 0.19A | 1ekjA-2a5vA:19.41ekjB-2a5vA:19.3 | 1ekjA-2a5vA:29.491ekjB-2a5vA:29.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EKJ_A_ACTA3001_0 (BETA-CARBONICANHYDRASE) |
2a5v | CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)(CARBONICDEHYDRATASE) (Mycobacteriumtuberculosis) | 5 / 8 | CYH A 51ASP A 53HIS A 104CYH A 107GLY A 108 | ZN A 401 ( 2.3A)SCN A 501 (-4.0A) ZN A 401 ( 3.3A) ZN A 401 ( 2.3A)SCN A 501 (-4.2A) | 1.02A | 1ekjA-2a5vA:19.41ekjB-2a5vA:19.3 | 1ekjA-2a5vA:29.491ekjB-2a5vA:29.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EKJ_A_ACTA3001_0 (BETA-CARBONICANHYDRASE) |
3vrk | CARBONYL SULFIDEHYDROLASE (Thiobacillusthioparus) | 5 / 8 | CYH A 44ASP A 46HIS A 97CYH A 100GLY A 101 | ZN A 301 (-2.2A)SCN A 303 (-4.2A) ZN A 301 (-3.2A) ZN A 301 (-2.3A)SCN A 303 ( 4.2A) | 0.23A | 1ekjA-3vrkA:13.51ekjB-3vrkA:13.7 | 1ekjA-3vrkA:24.691ekjB-3vrkA:24.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EKJ_A_ACTA3001_0 (BETA-CARBONICANHYDRASE) |
3vrk | CARBONYL SULFIDEHYDROLASE (Thiobacillusthioparus) | 5 / 8 | CYH A 44ASP A 46HIS A 97CYH A 100GLY A 101 | ZN A 301 (-2.2A)SCN A 303 (-4.2A) ZN A 301 (-3.2A) ZN A 301 (-2.3A)SCN A 303 ( 4.2A) | 0.91A | 1ekjA-3vrkA:13.51ekjB-3vrkA:13.7 | 1ekjA-3vrkA:24.691ekjB-3vrkA:24.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EKJ_A_ACTA3003_0 (BETA-CARBONICANHYDRASE) |
2a5v | CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)(CARBONICDEHYDRATASE) (Mycobacteriumtuberculosis) | 5 / 8 | CYH A 51ASP A 53HIS A 104CYH A 107GLY A 108 | ZN A 401 ( 2.3A)SCN A 501 (-4.0A) ZN A 401 ( 3.3A) ZN A 401 ( 2.3A)SCN A 501 (-4.2A) | 0.23A | 1ekjA-2a5vA:19.41ekjB-2a5vA:19.3 | 1ekjA-2a5vA:29.491ekjB-2a5vA:29.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EKJ_A_ACTA3003_0 (BETA-CARBONICANHYDRASE) |
3vrk | CARBONYL SULFIDEHYDROLASE (Thiobacillusthioparus) | 5 / 8 | CYH A 44ASP A 46HIS A 97CYH A 100GLY A 101 | ZN A 301 (-2.2A)SCN A 303 (-4.2A) ZN A 301 (-3.2A) ZN A 301 (-2.3A)SCN A 303 ( 4.2A) | 0.27A | 1ekjA-3vrkA:13.51ekjB-3vrkA:13.7 | 1ekjA-3vrkA:24.691ekjB-3vrkA:24.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EKJ_E_ACTE3005_0 (BETA-CARBONICANHYDRASE) |
2a5v | CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)(CARBONICDEHYDRATASE) (Mycobacteriumtuberculosis) | 4 / 7 | CYH A 51ASP A 53HIS A 104GLY A 108 | ZN A 401 ( 2.3A)SCN A 501 (-4.0A) ZN A 401 ( 3.3A)SCN A 501 (-4.2A) | 0.18A | 1ekjE-2a5vA:19.11ekjF-2a5vA:19.2 | 1ekjE-2a5vA:29.491ekjF-2a5vA:29.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EKJ_E_ACTE3005_0 (BETA-CARBONICANHYDRASE) |
2a5v | CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)(CARBONICDEHYDRATASE) (Mycobacteriumtuberculosis) | 4 / 7 | CYH A 51ASP A 53HIS A 104GLY A 108 | ZN A 401 ( 2.3A)SCN A 501 (-4.0A) ZN A 401 ( 3.3A)SCN A 501 (-4.2A) | 0.96A | 1ekjE-2a5vA:19.11ekjF-2a5vA:19.2 | 1ekjE-2a5vA:29.491ekjF-2a5vA:29.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EKJ_E_ACTE3005_0 (BETA-CARBONICANHYDRASE) |
3vrk | CARBONYL SULFIDEHYDROLASE (Thiobacillusthioparus) | 4 / 7 | ASP A 46HIS A 97GLY A 69GLY A 70 | SCN A 303 (-4.2A) ZN A 301 (-3.2A) ZN A 301 ( 4.3A)None | 0.84A | 1ekjE-3vrkA:13.21ekjF-3vrkA:13.1 | 1ekjE-3vrkA:24.691ekjF-3vrkA:24.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EKJ_E_ACTE3005_0 (BETA-CARBONICANHYDRASE) |
3vrk | CARBONYL SULFIDEHYDROLASE (Thiobacillusthioparus) | 4 / 7 | CYH A 44ASP A 46HIS A 97GLY A 101 | ZN A 301 (-2.2A)SCN A 303 (-4.2A) ZN A 301 (-3.2A)SCN A 303 ( 4.2A) | 0.18A | 1ekjE-3vrkA:13.21ekjF-3vrkA:13.1 | 1ekjE-3vrkA:24.691ekjF-3vrkA:24.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EKJ_G_ACTG3002_0 (BETA-CARBONICANHYDRASE) |
2a5v | CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)(CARBONICDEHYDRATASE) (Mycobacteriumtuberculosis) | 5 / 8 | CYH A 51ASP A 53HIS A 104CYH A 107GLY A 108 | ZN A 401 ( 2.3A)SCN A 501 (-4.0A) ZN A 401 ( 3.3A) ZN A 401 ( 2.3A)SCN A 501 (-4.2A) | 0.16A | 1ekjG-2a5vA:19.31ekjH-2a5vA:19.3 | 1ekjG-2a5vA:29.491ekjH-2a5vA:29.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EKJ_G_ACTG3002_0 (BETA-CARBONICANHYDRASE) |
2a5v | CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)(CARBONICDEHYDRATASE) (Mycobacteriumtuberculosis) | 5 / 8 | CYH A 51ASP A 53HIS A 104CYH A 107GLY A 108 | ZN A 401 ( 2.3A)SCN A 501 (-4.0A) ZN A 401 ( 3.3A) ZN A 401 ( 2.3A)SCN A 501 (-4.2A) | 1.00A | 1ekjG-2a5vA:19.31ekjH-2a5vA:19.3 | 1ekjG-2a5vA:29.491ekjH-2a5vA:29.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EKJ_G_ACTG3002_0 (BETA-CARBONICANHYDRASE) |
3vrk | CARBONYL SULFIDEHYDROLASE (Thiobacillusthioparus) | 5 / 8 | CYH A 44ASP A 46HIS A 97CYH A 100GLY A 101 | ZN A 301 (-2.2A)SCN A 303 (-4.2A) ZN A 301 (-3.2A) ZN A 301 (-2.3A)SCN A 303 ( 4.2A) | 0.19A | 1ekjG-3vrkA:13.81ekjH-3vrkA:13.3 | 1ekjG-3vrkA:24.691ekjH-3vrkA:24.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EKJ_G_ACTG3002_0 (BETA-CARBONICANHYDRASE) |
3vrk | CARBONYL SULFIDEHYDROLASE (Thiobacillusthioparus) | 5 / 8 | CYH A 44ASP A 46HIS A 97CYH A 100GLY A 101 | ZN A 301 (-2.2A)SCN A 303 (-4.2A) ZN A 301 (-3.2A) ZN A 301 (-2.3A)SCN A 303 ( 4.2A) | 0.88A | 1ekjG-3vrkA:13.81ekjH-3vrkA:13.3 | 1ekjG-3vrkA:24.691ekjH-3vrkA:24.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EKJ_H_ACTH3006_0 (BETA-CARBONICANHYDRASE) |
2a5v | CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)(CARBONICDEHYDRATASE) (Mycobacteriumtuberculosis) | 4 / 6 | CYH A 51ASP A 53HIS A 104CYH A 107 | ZN A 401 ( 2.3A)SCN A 501 (-4.0A) ZN A 401 ( 3.3A) ZN A 401 ( 2.3A) | 0.16A | 1ekjG-2a5vA:19.31ekjH-2a5vA:19.3 | 1ekjG-2a5vA:29.491ekjH-2a5vA:29.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EKJ_H_ACTH3006_0 (BETA-CARBONICANHYDRASE) |
3vrk | CARBONYL SULFIDEHYDROLASE (Thiobacillusthioparus) | 4 / 6 | CYH A 44ASP A 46HIS A 97CYH A 100 | ZN A 301 (-2.2A)SCN A 303 (-4.2A) ZN A 301 (-3.2A) ZN A 301 (-2.3A) | 0.20A | 1ekjG-3vrkA:13.71ekjH-3vrkA:13.3 | 1ekjG-3vrkA:24.691ekjH-3vrkA:24.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1IBG_H_OBNH1_2 (IGG2B-KAPPA 40-50FAB (HEAVY CHAIN)IGG2B-KAPPA 40-50FAB (LIGHT CHAIN)) |
4eb0 | LCC (unculturedbacterium) | 4 / 7 | THR A 144SER A 145ARG A 143LEU A 181 | SCN A 303 (-4.7A)SCN A 303 (-2.7A)NoneNone | 0.94A | 1ibgL-4eb0A:undetectable | 1ibgL-4eb0A:22.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JFF_B_TA1B601_1 (TUBULIN BETA CHAIN) |
2wl1 | PYRIN (Homosapiens) | 5 / 12 | VAL A 587LEU A 709HIS A 739SER A 728THR A 707 | NoneNoneNoneNoneSCN A1778 ( 4.7A) | 1.11A | 1jffB-2wl1A:undetectable | 1jffB-2wl1A:17.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1LII_A_ADNA699_1 (ADENOSINE KINASE) |
3uen | DNA TOPOISOMERASE2-BINDING PROTEIN 1 (Homosapiens) | 5 / 12 | ASP A 621LEU A 598GLY A 658THR A 614LEU A 633 | NoneSCN A 801 ( 3.9A)NoneSCN A 801 (-3.9A)None | 1.06A | 1liiA-3uenA:undetectable | 1liiA-3uenA:20.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MZ9_A_VDYA1002_2 (CARTILAGE OLIGOMERICMATRIX PROTEIN) |
2fno | AGR_PAT_752P (Agrobacteriumfabrum) | 3 / 3 | ILE A 194LEU A 197VAL A 201 | NoneNoneSCN A 238 ( 4.4A) | 0.45A | 1mz9B-2fnoA:undetectable | 1mz9B-2fnoA:11.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NW5_A_SAMA401_0 (MODIFICATIONMETHYLASE RSRI) |
3fkj | PUTATIVEPHOSPHOSUGARISOMERASES (Salmonellaenterica) | 5 / 12 | PHE A 293GLY A 295SER A 203ALA A 138ALA A 137 | NoneNoneNoneSCN A 329 ( 4.2A)SCN A 329 (-3.6A) | 1.24A | 1nw5A-3fkjA:undetectable | 1nw5A-3fkjA:22.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RG1_A_SPMA999_1 (TYROSYL-DNAPHOSPHODIESTERASE 1) |
5k9h | 0940_GH29 (unidentified) | 3 / 3 | TRP A 253VAL A 254PRO A 255 | NoneSCN A 621 ( 4.9A)None | 0.27A | 1rg1A-5k9hA:undetectable | 1rg1A-5k9hA:23.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RH0_A_SPMA999_1 (TYROSYL-DNAPHOSPHODIESTERASE 1) |
5k9h | 0940_GH29 (unidentified) | 3 / 3 | TRP A 253VAL A 254PRO A 255 | NoneSCN A 621 ( 4.9A)None | 0.28A | 1rh0A-5k9hA:undetectable | 1rh0A-5k9hA:23.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1SKX_A_RFPA1_2 (ORPHAN NUCLEARRECEPTOR PXR) |
5e2g | BETA-LACTAMASE (Burkholderiacenocepacia) | 4 / 5 | PHE A 165LEU A 101MET A 161LEU A 243 | NoneNoneNoneSCN A 402 ( 4.0A) | 1.42A | 1skxA-5e2gA:undetectable | 1skxA-5e2gA:20.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UWJ_A_BAXA1723_2 (B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE) |
3kxi | GTP-BINDING PROTEIN(HFLX) (Sulfolobussolfataricus) | 4 / 7 | LYS A 321ILE A 262ILE A 333ASP A 329 | NoneNoneSCN A 366 (-3.5A)None | 0.81A | 1uwjA-3kxiA:undetectable | 1uwjA-3kxiA:21.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Y7I_A_SALA502_1 (SALICYLICACID-BINDING PROTEIN2) |
1sq4 | GLYOXYLATE-INDUCEDPROTEIN (Pseudomonasaeruginosa) | 3 / 3 | LEU A 262HIS A 214LYS A 264 | SCN A 302 ( 4.5A)NoneSCN A 302 ( 3.9A) | 0.99A | 1y7iA-1sq4A:undetectable | 1y7iA-1sq4A:22.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AOI_C_FRDC305_2 (POL POLYPROTEINPEPTIDE INHIBITOR) |
3tl2 | MALATE DEHYDROGENASE (Bacillusanthracis) | 4 / 5 | LEU A 270ASP A 128PRO A 254ILE A 256 | NoneSCN A 314 (-3.7A)NoneNone | 0.95A | 2aoiB-3tl2A:undetectable | 2aoiB-3tl2A:16.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BXQ_A_P1ZA2002_1 (SERUM ALBUMIN) |
2fno | AGR_PAT_752P (Agrobacteriumfabrum) | 6 / 12 | LEU A 172LEU A 112LEU A 133ILE A 137ILE A 187ALA A 177 | NoneNoneNoneNoneSCN A 237 ( 3.9A)SCN A 237 (-3.4A) | 1.34A | 2bxqA-2fnoA:undetectable | 2bxqA-2fnoA:16.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G72_A_SAMA2001_1 (PHENYLETHANOLAMINEN-METHYLTRANSFERASE) |
4l37 | SILKWORM STORAGEPROTEIN (Bombyxmori) | 4 / 6 | TYR A 144GLY A 214TYR A 221ASP A 212 | NoneSCN A 711 ( 4.4A)NoneNone | 1.17A | 2g72A-4l37A:undetectable | 2g72A-4l37A:15.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2GJ5_A_VD3A164_1 (BETA-LACTOGLOBULIN) |
5e2g | BETA-LACTAMASE (Burkholderiacenocepacia) | 4 / 5 | ASP A 71LEU A 68MET A 169ARG A 172 | SCN A 402 ( 3.7A)NoneNoneSCN A 402 ( 4.7A) | 1.25A | 2gj5A-5e2gA:undetectable | 2gj5A-5e2gA:20.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HMA_A_SAMA375_0 (PROBABLE TRNA(5-METHYLAMINOMETHYL-2-THIOURIDYLATE)-METHYLTRANSFERASE) |
3v48 | PUTATIVEAMINOACRYLATEHYDROLASE RUTD (Escherichiacoli) | 5 / 11 | GLY A 26SER A 20GLY A 24GLN A 173PHE A 172 | NoneNoneNoneSCN A 269 ( 4.8A)None | 1.28A | 2hmaA-3v48A:undetectable | 2hmaA-3v48A:20.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HXF_B_TA1B601_1 (TUBULIN BETA CHAIN) |
2wl1 | PYRIN (Homosapiens) | 5 / 12 | VAL A 587LEU A 709HIS A 739SER A 728THR A 707 | NoneNoneNoneNoneSCN A1778 ( 4.7A) | 1.11A | 2hxfB-2wl1A:undetectable | 2hxfB-2wl1A:17.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HXH_B_TA1B601_1 (TUBULIN BETA CHAIN) |
2wl1 | PYRIN (Homosapiens) | 5 / 12 | VAL A 587LEU A 709HIS A 739SER A 728THR A 707 | NoneNoneNoneNoneSCN A1778 ( 4.7A) | 1.11A | 2hxhB-2wl1A:undetectable | 2hxhB-2wl1A:17.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2J2P_B_SC2B1294_1 (FICOLIN-2) |
3pvz | UDP-N-ACETYLGLUCOSAMINE 4,6-DEHYDRATASE (Aliivibriofischeri) | 5 / 9 | GLY A 205SER A 206LEU A 208SER A 203ASP A 204 | NoneSCN A 604 (-3.7A)SCN A 604 ( 3.9A)NAD A 501 (-2.9A)None | 1.27A | 2j2pB-3pvzA:undetectable2j2pC-3pvzA:undetectable | 2j2pB-3pvzA:18.412j2pC-3pvzA:18.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JN3_A_JN3A130_2 (FATTY ACID-BINDINGPROTEIN, LIVER) |
3hk0 | GROWTH FACTORRECEPTOR-BOUNDPROTEIN 10 (Homosapiens) | 4 / 7 | LEU A 227LEU A 223GLU A 167ARG A 337 | NoneNoneNoneSCN A 15 (-3.8A) | 0.98A | 2jn3A-3hk0A:undetectable | 2jn3A-3hk0A:18.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2P4N_B_TA1B601_1 (TUBULIN BETA CHAIN) |
2wl1 | PYRIN (Homosapiens) | 5 / 12 | VAL A 587LEU A 709HIS A 739SER A 728THR A 707 | NoneNoneNoneNoneSCN A1778 ( 4.7A) | 1.11A | 2p4nB-2wl1A:undetectable | 2p4nB-2wl1A:17.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q6K_A_ADNA699_1 (CHLORINASE) |
4l37 | SILKWORM STORAGEPROTEIN (Bombyxmori) | 4 / 7 | TYR A 221TYR A 218PRO A 588THR A 586 | NoneNoneSCN A 711 ( 4.7A)None | 1.31A | 2q6kA-4l37A:undetectable | 2q6kA-4l37A:16.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2QQT_A_AINA596_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 6 / 6 | HIS A 95ARG A 239GLU A 242PHE A 366GLN A 408PRO A 409 | SCN A1502 ( 4.8A)HEM A 605 (-4.7A)HEM A 605 ( 2.2A)NoneHEM A 605 ( 4.6A)None | 0.38A | 2qqtA-2gjmA:65.6 | 2qqtA-2gjmA:99.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2V32_D_BEZD1221_0 (PEROXIREDOXIN 6) |
3tl2 | MALATE DEHYDROGENASE (Bacillusanthracis) | 4 / 8 | VAL A 127PRO A 126VAL A 304SER A 303 | SCN A 314 (-4.8A)EDO A 313 ( 3.7A)SCN A 314 ( 3.9A)None | 0.94A | 2v32C-3tl2A:undetectable2v32D-3tl2A:2.3 | 2v32C-3tl2A:22.562v32D-3tl2A:22.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDING GLOBULIN) |
5bu6 | BPSB (PGAB),POLY-BETA-1,6-N-ACETYL-D-GLUCOSAMINEN-DEACETYLASE (Bordetellabronchiseptica) | 5 / 12 | SER A 47THR A 42ARG A 290ILE A 288PHE A 43 | NoneNoneSCN A 404 (-4.1A)NoneNone | 1.15A | 2vdyA-5bu6A:undetectable | 2vdyA-5bu6A:22.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2WBE_B_TA1B1439_1 (TUBULIN BETA-2BCHAIN) |
2wl1 | PYRIN (Homosapiens) | 5 / 12 | VAL A 587LEU A 709HIS A 739SER A 728THR A 707 | NoneNoneNoneNoneSCN A1778 ( 4.7A) | 1.11A | 2wbeB-2wl1A:undetectable | 2wbeB-2wl1A:17.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Y7K_A_SALA1302_1 (LYSR-TYPE REGULATORYPROTEIN) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 7 / 11 | THR A 104GLY A 107GLY A 152PHE A 167HIS A 206PRO A 246ILE A 273 | SCN A1307 (-4.0A)SCN A1303 (-3.5A)SCN A1307 (-3.6A)SCN A1303 (-4.7A)SCN A1307 (-3.6A)NoneSCN A1303 (-4.1A) | 0.92A | 2y7kA-2uyeA:30.2 | 2y7kA-2uyeA:70.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Y7K_A_SALA1302_1 (LYSR-TYPE REGULATORYPROTEIN) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 7 / 11 | THR A 104ILE A 106GLY A 107GLY A 152PHE A 167PRO A 246ILE A 273 | SCN A1307 (-4.0A)SCN A1303 ( 4.9A)SCN A1303 (-3.5A)SCN A1307 (-3.6A)SCN A1303 (-4.7A)NoneSCN A1303 (-4.1A) | 0.86A | 2y7kA-2uyeA:30.2 | 2y7kA-2uyeA:70.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Y7K_B_SALB1304_1 (LYSR-TYPE REGULATORYPROTEIN) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 6 / 10 | THR A 104GLY A 107PHE A 167HIS A 206PRO A 246ILE A 273 | SCN A1307 (-4.0A)SCN A1303 (-3.5A)SCN A1303 (-4.7A)SCN A1307 (-3.6A)NoneSCN A1303 (-4.1A) | 0.89A | 2y7kB-2uyeA:30.5 | 2y7kB-2uyeA:70.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Y7K_B_SALB1304_1 (LYSR-TYPE REGULATORYPROTEIN) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 6 / 10 | THR A 104ILE A 106GLY A 107PHE A 167PRO A 246ILE A 273 | SCN A1307 (-4.0A)SCN A1303 ( 4.9A)SCN A1303 (-3.5A)SCN A1303 (-4.7A)NoneSCN A1303 (-4.1A) | 0.82A | 2y7kB-2uyeA:30.5 | 2y7kB-2uyeA:70.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Y7K_C_SALC1302_1 (LYSR-TYPE REGULATORYPROTEIN) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 5 / 12 | GLY A 152PHE A 167HIS A 169PRO A 246ILE A 273 | SCN A1307 (-3.6A)SCN A1303 (-4.7A)SCN A1303 (-4.4A)NoneSCN A1303 (-4.1A) | 1.22A | 2y7kC-2uyeA:32.6 | 2y7kC-2uyeA:70.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Y7K_C_SALC1302_1 (LYSR-TYPE REGULATORYPROTEIN) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 8 / 12 | THR A 104ILE A 106GLY A 107GLY A 152PHE A 167HIS A 206PRO A 246ILE A 273 | SCN A1307 (-4.0A)SCN A1303 ( 4.9A)SCN A1303 (-3.5A)SCN A1307 (-3.6A)SCN A1303 (-4.7A)SCN A1307 (-3.6A)NoneSCN A1303 (-4.1A) | 0.77A | 2y7kC-2uyeA:32.6 | 2y7kC-2uyeA:70.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Y7K_D_SALD1300_1 (LYSR-TYPE REGULATORYPROTEIN) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 5 / 12 | GLY A 152PHE A 167HIS A 169PRO A 246ILE A 273 | SCN A1307 (-3.6A)SCN A1303 (-4.7A)SCN A1303 (-4.4A)NoneSCN A1303 (-4.1A) | 1.23A | 2y7kD-2uyeA:31.6 | 2y7kD-2uyeA:70.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Y7K_D_SALD1300_1 (LYSR-TYPE REGULATORYPROTEIN) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 8 / 12 | THR A 104ILE A 106GLY A 107GLY A 152PHE A 167HIS A 206PRO A 246ILE A 273 | SCN A1307 (-4.0A)SCN A1303 ( 4.9A)SCN A1303 (-3.5A)SCN A1307 (-3.6A)SCN A1303 (-4.7A)SCN A1307 (-3.6A)NoneSCN A1303 (-4.1A) | 0.71A | 2y7kD-2uyeA:31.6 | 2y7kD-2uyeA:70.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Y7P_A_SALA1000_1 (LYSR-TYPE REGULATORYPROTEIN) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 5 / 10 | GLY A 152PHE A 167HIS A 169PRO A 246ILE A 273 | SCN A1307 (-3.6A)SCN A1303 (-4.7A)SCN A1303 (-4.4A)NoneSCN A1303 (-4.1A) | 1.31A | 2y7pA-2uyeA:30.1 | 2y7pA-2uyeA:70.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Y7P_A_SALA1000_1 (LYSR-TYPE REGULATORYPROTEIN) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 7 / 10 | THR A 104GLY A 107GLY A 152PHE A 167HIS A 206PRO A 246ILE A 273 | SCN A1307 (-4.0A)SCN A1303 (-3.5A)SCN A1307 (-3.6A)SCN A1303 (-4.7A)SCN A1307 (-3.6A)NoneSCN A1303 (-4.1A) | 0.94A | 2y7pA-2uyeA:30.1 | 2y7pA-2uyeA:70.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Y7P_A_SALA1000_1 (LYSR-TYPE REGULATORYPROTEIN) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 7 / 10 | THR A 104ILE A 106GLY A 107GLY A 152PHE A 167PRO A 246ILE A 273 | SCN A1307 (-4.0A)SCN A1303 ( 4.9A)SCN A1303 (-3.5A)SCN A1307 (-3.6A)SCN A1303 (-4.7A)NoneSCN A1303 (-4.1A) | 0.92A | 2y7pA-2uyeA:30.1 | 2y7pA-2uyeA:70.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Y7W_A_SALA1300_1 (LYSR-TYPE REGULATORYPROTEIN) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 6 / 9 | THR A 104ILE A 106GLY A 107GLY A 152PHE A 167ILE A 273 | SCN A1307 (-4.0A)SCN A1303 ( 4.9A)SCN A1303 (-3.5A)SCN A1307 (-3.6A)SCN A1303 (-4.7A)SCN A1303 (-4.1A) | 0.59A | 2y7wA-2uyeA:20.4 | 2y7wA-2uyeA:73.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Y7W_B_SALB1300_1 (LYSR-TYPE REGULATORYPROTEIN) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 6 / 10 | THR A 104GLY A 107GLY A 152HIS A 206PRO A 246ILE A 273 | SCN A1307 (-4.0A)SCN A1303 (-3.5A)SCN A1307 (-3.6A)SCN A1307 (-3.6A)NoneSCN A1303 (-4.1A) | 0.74A | 2y7wB-2uyeA:30.7 | 2y7wB-2uyeA:73.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Y7W_B_SALB1300_1 (LYSR-TYPE REGULATORYPROTEIN) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 6 / 10 | THR A 104GLY A 107THR A 204HIS A 206PRO A 246ILE A 273 | SCN A1307 (-4.0A)SCN A1303 (-3.5A)SCN A1309 ( 4.7A)SCN A1307 (-3.6A)NoneSCN A1303 (-4.1A) | 0.90A | 2y7wB-2uyeA:30.7 | 2y7wB-2uyeA:73.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Y7W_B_SALB1300_1 (LYSR-TYPE REGULATORYPROTEIN) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 6 / 10 | THR A 104ILE A 106GLY A 107GLY A 152PRO A 246ILE A 273 | SCN A1307 (-4.0A)SCN A1303 ( 4.9A)SCN A1303 (-3.5A)SCN A1307 (-3.6A)NoneSCN A1303 (-4.1A) | 0.33A | 2y7wB-2uyeA:30.7 | 2y7wB-2uyeA:73.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Y7W_B_SALB1300_1 (LYSR-TYPE REGULATORYPROTEIN) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 6 / 10 | THR A 104ILE A 106GLY A 107THR A 204PRO A 246ILE A 273 | SCN A1307 (-4.0A)SCN A1303 ( 4.9A)SCN A1303 (-3.5A)SCN A1309 ( 4.7A)NoneSCN A1303 (-4.1A) | 0.56A | 2y7wB-2uyeA:30.7 | 2y7wB-2uyeA:73.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2Y7W_C_SALC1300_1 (LYSR-TYPE REGULATORYPROTEIN) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 5 / 7 | THR A 104ILE A 106GLY A 107PHE A 167ILE A 273 | SCN A1307 (-4.0A)SCN A1303 ( 4.9A)SCN A1303 (-3.5A)SCN A1303 (-4.7A)SCN A1303 (-4.1A) | 0.64A | 2y7wC-2uyeA:30.7 | 2y7wC-2uyeA:73.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YDO_A_ADNA400_1 (ADENOSINE RECEPTORA2A) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 5 / 12 | LEU A 151THR A 104PHE A 167GLU A 300HIS A 206 | NoneSCN A1307 (-4.0A)SCN A1303 (-4.7A)NoneSCN A1307 (-3.6A) | 0.98A | 2ydoA-2uyeA:undetectable | 2ydoA-2uyeA:22.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AOD_C_RFPC2002_1 (ACRIFLAVINERESISTANCE PROTEIN B) |
4eb0 | LCC (unculturedbacterium) | 5 / 12 | GLN A 134PHE A 125ASN A 120GLY A 72ARG A 65 | NoneSCN A 302 ( 4.8A)NoneNoneNone | 1.37A | 3aodC-4eb0A:undetectable | 3aodC-4eb0A:13.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B9L_A_AZZA1010_1 (SERUM ALBUMIN) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 4 / 8 | LEU A 151ILE A 273HIS A 169GLY A 205 | NoneSCN A1303 (-4.1A)SCN A1303 (-4.4A)SCN A1307 (-3.5A) | 0.96A | 3b9lA-2uyeA:undetectable | 3b9lA-2uyeA:19.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BXO_B_SAMB238_1 (N,N-DIMETHYLTRANSFERASE) |
5k9h | 0940_GH29 (unidentified) | 3 / 3 | TYR A 286GLU A 360ASP A 362 | SCN A 624 ( 4.7A)NoneNone | 0.87A | 3bxoB-5k9hA:undetectable | 3bxoB-5k9hA:14.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CR5_X_PNTX94_0 (PROTEIN S100-B) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 3 / 3 | PHE A 249CYH A 253PHE A 257 | SCN A1305 (-4.8A)SCN A1305 ( 4.1A)None | 1.13A | 3cr5X-2uyeA:undetectable | 3cr5X-2uyeA:14.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DCO_B_TA1B601_1 (BOVINE BETA TUBULIN) |
2wl1 | PYRIN (Homosapiens) | 5 / 12 | VAL A 587LEU A 709HIS A 739SER A 728THR A 707 | NoneNoneNoneNoneSCN A1778 ( 4.7A) | 1.11A | 3dcoB-2wl1A:undetectable | 3dcoB-2wl1A:17.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EDL_B_TA1B601_1 (BETA TUBULIN) |
2wl1 | PYRIN (Homosapiens) | 5 / 12 | VAL A 587LEU A 709HIS A 739SER A 728THR A 707 | NoneNoneNoneNoneSCN A1778 ( 4.7A) | 1.10A | 3edlB-2wl1A:undetectable | 3edlB-2wl1A:17.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ELW_A_SAMA4633_0 (METHYLTRANSFERASE) |
2a5v | CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)(CARBONICDEHYDRATASE) (Mycobacteriumtuberculosis) | 5 / 12 | GLY A 108GLY A 103GLY A 76PHE A 20ASP A 53 | SCN A 501 (-4.2A)None ZN A 401 ( 4.4A)NoneSCN A 501 (-4.0A) | 0.90A | 3elwA-2a5vA:undetectable | 3elwA-2a5vA:24.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GCL_A_AINA609_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 6 / 6 | HIS A 95ARG A 239GLU A 242PHE A 366GLN A 408PRO A 409 | SCN A1502 ( 4.8A)HEM A 605 (-4.7A)HEM A 605 ( 2.2A)NoneHEM A 605 ( 4.6A)None | 0.52A | 3gclA-2gjmA:61.4 | 3gclA-2gjmA:99.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GCZ_A_SAMA4633_0 (POLYPROTEIN) |
4a6u | OMEGA TRANSAMINASE (Chromobacteriumviolaceum) | 5 / 12 | SER A 291GLY A 293GLY A 120GLY A 298GLY A 289 | NoneSCN A 602 ( 4.8A)NoneNoneNone | 0.92A | 3gczA-4a6uA:undetectable | 3gczA-4a6uA:20.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3I5U_A_SAMA401_0 (O-METHYLTRANSFERASE) |
3v48 | PUTATIVEAMINOACRYLATEHYDROLASE RUTD (Escherichiacoli) | 5 / 12 | PHE A 125HIS A 237LEU A 148GLY A 23ALA A 88 | NoneSCN A 270 (-3.8A)GOL A 267 (-4.7A)GOL A 267 ( 3.5A)SCN A 270 (-3.3A) | 1.04A | 3i5uA-3v48A:undetectable | 3i5uA-3v48A:23.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3IK3_A_0LIA1_2 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) |
1sq4 | GLYOXYLATE-INDUCEDPROTEIN (Pseudomonasaeruginosa) | 4 / 7 | LEU A 262TYR A 260VAL A 37ILE A 57 | SCN A 302 ( 4.5A)NoneNoneNone | 1.32A | 3ik3A-1sq4A:undetectable | 3ik3A-1sq4A:19.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3IK3_B_0LIB2_2 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) |
1sq4 | GLYOXYLATE-INDUCEDPROTEIN (Pseudomonasaeruginosa) | 4 / 7 | LEU A 262TYR A 260VAL A 37ILE A 57 | SCN A 302 ( 4.5A)NoneNoneNone | 1.28A | 3ik3B-1sq4A:undetectable | 3ik3B-1sq4A:19.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3IZ0_B_TA1B820_1 (BETA TUBULIN, CHAINB FROM PDB 1JFF) |
2wl1 | PYRIN (Homosapiens) | 5 / 12 | VAL A 587LEU A 709HIS A 739SER A 728THR A 707 | NoneNoneNoneNoneSCN A1778 ( 4.7A) | 1.11A | 3iz0B-2wl1A:undetectable | 3iz0B-2wl1A:17.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3J6P_B_TA1B502_1 (TUBULIN BETA CHAIN) |
2wl1 | PYRIN (Homosapiens) | 5 / 12 | VAL A 587LEU A 709HIS A 739SER A 728THR A 707 | NoneNoneNoneNoneSCN A1778 ( 4.7A) | 1.14A | 3j6pB-2wl1A:undetectable | 3j6pB-2wl1A:17.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KU9_B_SPMB700_1 (POLYAMINE OXIDASE) |
4l37 | ARYLPHORIN (Bombyxmori) | 4 / 7 | TYR B 222TYR B 402TYR B 126PHE B 81 | NoneSCN B 708 (-4.8A)NoneNone | 1.38A | 3ku9B-4l37B:undetectable | 3ku9B-4l37B:21.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LUS_B_X8ZB1001_1 (ORGANICHYDROPEROXIDERESISTANCE PROTEIN) |
6d9n | ORGANICHYDROPEROXIDERESISTANCE PROTEIN (Elizabethkingiaanophelis) | 5 / 9 | TYR A 32PRO A 33PRO A 46GLU A 47PHE A 92 | NoneNoneSCN A 202 ( 4.3A)SCN A 202 (-3.5A)None | 0.61A | 3lusA-6d9nA:17.03lusB-6d9nA:18.3 | 3lusA-6d9nA:41.463lusB-6d9nA:41.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MES_A_DMEA427_1 (CHOLINE KINASE) |
4l37 | ARYLPHORIN (Bombyxmori) | 5 / 10 | SER B 235GLN B 356ASN B 358GLU B 375TYR B 402 | NoneSCN B 708 (-4.2A)NoneSCN B 708 (-3.8A)SCN B 708 (-4.8A) | 1.41A | 3mesA-4l37B:undetectable | 3mesA-4l37B:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MES_B_DMEB427_1 (CHOLINE KINASE) |
4l37 | ARYLPHORIN (Bombyxmori) | 5 / 10 | SER B 235GLN B 356ASN B 358GLU B 375TYR B 402 | NoneSCN B 708 (-4.2A)NoneSCN B 708 (-3.8A)SCN B 708 (-4.8A) | 1.43A | 3mesB-4l37B:undetectable | 3mesB-4l37B:20.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3OGW_A_IMNA597_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 8 / 9 | GLN A 91HIS A 95PHE A 99GLU A 102ARG A 239GLU A 242PHE A 366GLN A 408 | HEM A 605 (-3.4A)SCN A1502 ( 4.8A)HEM A 605 (-4.8A)NoneHEM A 605 (-4.7A)HEM A 605 ( 2.2A)NoneHEM A 605 ( 4.6A) | 0.50A | 3ogwA-2gjmA:65.8 | 3ogwA-2gjmA:99.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OU6_B_SAMB300_1 (SAM-DEPENDENTMETHYLTRANSFERASE) |
4l37 | SILKWORM STORAGEPROTEIN (Bombyxmori) | 3 / 3 | TYR A 190ASP A 457ASP A 560 | NoneNoneSCN A 711 (-4.2A) | 0.85A | 3ou6B-4l37A:undetectable | 3ou6B-4l37A:14.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OU6_C_SAMC300_1 (SAM-DEPENDENTMETHYLTRANSFERASE) |
4l37 | SILKWORM STORAGEPROTEIN (Bombyxmori) | 3 / 3 | TYR A 144GLY A 214ASP A 212 | NoneSCN A 711 ( 4.4A)None | 0.73A | 3ou6C-4l37A:undetectable | 3ou6C-4l37A:14.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PFG_A_SAMA264_0 (N-METHYLTRANSFERASE) |
3kxi | GTP-BINDING PROTEIN(HFLX) (Sulfolobussolfataricus) | 5 / 12 | ALA A 335GLY A 191LEU A 336PHE A 196SER A 198 | GDP A 500 (-3.8A)GDP A 500 (-3.2A)GDP A 500 (-3.9A)NoneSCN A 366 ( 4.0A) | 1.21A | 3pfgA-3kxiA:2.5 | 3pfgA-3kxiA:20.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3PY4_A_TYLA598_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 5 / 5 | GLN A 91HIS A 95ARG A 239GLU A 242PHE A 366 | HEM A 605 (-3.4A)SCN A1502 ( 4.8A)HEM A 605 (-4.7A)HEM A 605 ( 2.2A)None | 0.37A | 3py4A-2gjmA:65.9 | 3py4A-2gjmA:99.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3QF1_A_PZEA6951_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 3 / 3 | HIS A 95ARG A 239GLU A 242 | SCN A1502 ( 4.8A)HEM A 605 (-4.7A)HEM A 605 ( 2.2A) | 0.45A | 3qf1A-2gjmA:60.5 | 3qf1A-2gjmA:95.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3QL6_A_NIMA614_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 7 / 7 | GLN A 91HIS A 95GLU A 102ARG A 239GLU A 242PHE A 366PRO A 409 | HEM A 605 (-3.4A)SCN A1502 ( 4.8A)NoneHEM A 605 (-4.7A)HEM A 605 ( 2.2A)NoneNone | 0.64A | 3ql6A-2gjmA:60.6 | 3ql6A-2gjmA:99.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R4X_A_PZAA597_0 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 5 / 5 | GLN A 91ASP A 94HIS A 95ARG A 239GLU A 242 | HEM A 605 (-3.4A)HEM A 605 (-2.0A)SCN A1502 ( 4.8A)HEM A 605 (-4.7A)HEM A 605 ( 2.2A) | 0.45A | 3r4xA-2gjmA:60.9 | 3r4xA-2gjmA:99.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3R55_A_PZAA597_0 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 5 / 5 | GLN A 91ASP A 94HIS A 95ARG A 239GLU A 242 | HEM A 605 (-3.4A)HEM A 605 (-2.0A)SCN A1502 ( 4.8A)HEM A 605 (-4.7A)HEM A 605 ( 2.2A) | 0.39A | 3r55A-2gjmA:61.1 | 3r55A-2gjmA:95.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TGY_A_ASCA800_0 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 4 / 4 | HIS A 95ARG A 239GLU A 242PHE A 366 | SCN A1502 ( 4.8A)HEM A 605 (-4.7A)HEM A 605 ( 2.2A)None | 0.50A | 3tgyA-2gjmA:60.1 | 3tgyA-2gjmA:99.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UCJ_A_AZMA229_1 (CARBONIC ANHYDRASE) |
2a5v | CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)(CARBONICDEHYDRATASE) (Mycobacteriumtuberculosis) | 7 / 10 | CYH A 51ASP A 53HIS A 104CYH A 107GLY A 108ALA A 109ALA A 112 | ZN A 401 ( 2.3A)SCN A 501 (-4.0A) ZN A 401 ( 3.3A) ZN A 401 ( 2.3A)SCN A 501 (-4.2A)SCN A 501 ( 4.4A)None | 0.27A | 3ucjA-2a5vA:19.1 | 3ucjA-2a5vA:27.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UCJ_A_AZMA229_1 (CARBONIC ANHYDRASE) |
2a5v | CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)(CARBONICDEHYDRATASE) (Mycobacteriumtuberculosis) | 5 / 10 | CYH A 51HIS A 104CYH A 107ALA A 109ALA A 113 | ZN A 401 ( 2.3A) ZN A 401 ( 3.3A) ZN A 401 ( 2.3A)SCN A 501 ( 4.4A)None | 1.15A | 3ucjA-2a5vA:19.1 | 3ucjA-2a5vA:27.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UCJ_A_AZMA229_1 (CARBONIC ANHYDRASE) |
3vrk | CARBONYL SULFIDEHYDROLASE (Thiobacillusthioparus) | 6 / 10 | CYH A 44ASP A 46HIS A 97CYH A 100GLY A 101ALA A 104 | ZN A 301 (-2.2A)SCN A 303 (-4.2A) ZN A 301 (-3.2A) ZN A 301 (-2.3A)SCN A 303 ( 4.2A)None | 1.11A | 3ucjA-3vrkA:13.9 | 3ucjA-3vrkA:28.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UCJ_B_AZMB229_2 (CARBONIC ANHYDRASE) |
2a5v | CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)(CARBONICDEHYDRATASE) (Mycobacteriumtuberculosis) | 7 / 10 | CYH A 51ASP A 53HIS A 104CYH A 107GLY A 108ALA A 109ALA A 112 | ZN A 401 ( 2.3A)SCN A 501 (-4.0A) ZN A 401 ( 3.3A) ZN A 401 ( 2.3A)SCN A 501 (-4.2A)SCN A 501 ( 4.4A)None | 0.27A | 3ucjB-2a5vA:19.8 | 3ucjB-2a5vA:27.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UCJ_B_AZMB229_2 (CARBONIC ANHYDRASE) |
2a5v | CARBONIC ANHYDRASE(CARBONATEDEHYDRATASE)(CARBONICDEHYDRATASE) (Mycobacteriumtuberculosis) | 5 / 10 | CYH A 51HIS A 104CYH A 107ALA A 109ALA A 113 | ZN A 401 ( 2.3A) ZN A 401 ( 3.3A) ZN A 401 ( 2.3A)SCN A 501 ( 4.4A)None | 1.15A | 3ucjB-2a5vA:19.8 | 3ucjB-2a5vA:27.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UCJ_B_AZMB229_2 (CARBONIC ANHYDRASE) |
3vrk | CARBONYL SULFIDEHYDROLASE (Thiobacillusthioparus) | 5 / 10 | CYH A 44ASP A 46HIS A 97CYH A 100ALA A 147 | ZN A 301 (-2.2A)SCN A 303 (-4.2A) ZN A 301 (-3.2A) ZN A 301 (-2.3A)None | 1.11A | 3ucjB-3vrkA:14.2 | 3ucjB-3vrkA:28.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UCJ_B_AZMB229_2 (CARBONIC ANHYDRASE) |
3vrk | CARBONYL SULFIDEHYDROLASE (Thiobacillusthioparus) | 6 / 10 | CYH A 44ASP A 46HIS A 97CYH A 100GLY A 101ALA A 104 | ZN A 301 (-2.2A)SCN A 303 (-4.2A) ZN A 301 (-3.2A) ZN A 301 (-2.3A)SCN A 303 ( 4.2A)None | 1.14A | 3ucjB-3vrkA:14.2 | 3ucjB-3vrkA:28.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UVV_A_T3A501_1 (THYROID HORMONERECEPTOR ALPHA) |
2pa5 | TYROSINE-PROTEINPHOSPHATASENON-RECEPTOR TYPE 9 (Homosapiens) | 5 / 12 | ILE A 481ALA A 477LEU A 535LEU A 541ILE A 288 | SCN A 601 (-3.5A)SCN A 601 ( 4.3A)NoneNoneNone | 0.97A | 3uvvA-2pa5A:undetectable | 3uvvA-2pa5A:21.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UVV_A_T3A501_1 (THYROID HORMONERECEPTOR ALPHA) |
2pa5 | TYROSINE-PROTEINPHOSPHATASENON-RECEPTOR TYPE 9 (Homosapiens) | 5 / 12 | ILE A 481ALA A 575LEU A 535LEU A 541ILE A 288 | SCN A 601 (-3.5A)NoneNoneNoneNone | 0.83A | 3uvvA-2pa5A:undetectable | 3uvvA-2pa5A:21.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ZMD_A_SALA201_1 (PUTATIVETRANSCRIPTIONALREGULATOR) |
3bxh | CENTRAL GLYCOLYTICGENE REGULATOR (Bacillussubtilis) | 4 / 8 | LEU A 178ARG A 251TYR A 273GLU A 269 | SCN A 1 (-4.4A)F6P A 401 (-3.7A)NoneF6P A 401 (-2.9A) | 1.33A | 3zmdA-3bxhA:undetectable3zmdB-3bxhA:undetectable | 3zmdA-3bxhA:18.533zmdB-3bxhA:18.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDING GLOBULIN) |
5bu6 | BPSB (PGAB),POLY-BETA-1,6-N-ACETYL-D-GLUCOSAMINEN-DEACETYLASE (Bordetellabronchiseptica) | 5 / 12 | SER A 47THR A 42ARG A 290ILE A 288PHE A 43 | NoneNoneSCN A 404 (-4.1A)NoneNone | 1.22A | 4c49C-5bu6A:undetectable | 4c49C-5bu6A:21.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FGK_A_0TXA304_0 (RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE[QUINONE]) |
3tl2 | MALATE DEHYDROGENASE (Bacillusanthracis) | 5 / 10 | GLY A 218GLY A 217ASN A 125VAL A 127GLN A 148 | NoneNoneEDO A 313 ( 4.4A)SCN A 314 (-4.8A)None | 1.47A | 4fgkA-3tl2A:5.14fgkB-3tl2A:5.3 | 4fgkA-3tl2A:21.914fgkB-3tl2A:21.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4GN6_A_TYLA621_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 4 / 4 | HIS A 95ARG A 239GLU A 242PHE A 366 | SCN A1502 ( 4.8A)HEM A 605 (-4.7A)HEM A 605 ( 2.2A)None | 0.39A | 4gn6A-2gjmA:65.0 | 4gn6A-2gjmA:99.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HBF_A_DXCA75_0 (PPCA) |
4pdy | AMINOGLYCOSIDEPHOSPHOTRANSFERASE (Alicyclobacillusacidocaldarius) | 4 / 7 | LEU A 299LYS A 334PHE A 338GLY A 271 | NoneNoneNoneSCN A 409 ( 4.7A) | 1.06A | 4hbfA-4pdyA:undetectable | 4hbfA-4pdyA:9.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HC3_A_DXCA75_0 (PPCA) |
4pdy | AMINOGLYCOSIDEPHOSPHOTRANSFERASE (Alicyclobacillusacidocaldarius) | 4 / 7 | LEU A 299LYS A 334PHE A 338GLY A 271 | NoneNoneNoneSCN A 409 ( 4.7A) | 1.01A | 4hc3A-4pdyA:undetectable | 4hc3A-4pdyA:10.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IG5_A_MMZA616_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 5 / 5 | GLN A 91HIS A 95ARG A 239GLU A 242LEU A 246 | HEM A 605 (-3.4A)SCN A1502 ( 4.8A)HEM A 605 (-4.7A)HEM A 605 ( 2.2A)None | 0.43A | 4ig5A-2gjmA:59.5 | 4ig5A-2gjmA:95.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4IG5_B_MMZB617_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 5 / 5 | GLN A 91HIS A 95ARG A 239GLU A 242LEU A 246 | HEM A 605 (-3.4A)SCN A1502 ( 4.8A)HEM A 605 (-4.7A)HEM A 605 ( 2.2A)None | 0.37A | 4ig5B-2gjmA:60.0 | 4ig5B-2gjmA:95.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QYQ_A_3CJA607_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 3 / 3 | GLN A 91HIS A 95ARG A 239 | HEM A 605 (-3.4A)SCN A1502 ( 4.8A)HEM A 605 (-4.7A) | 0.40A | 4qyqA-2gjmA:59.2 | 4qyqA-2gjmA:95.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QYQ_B_3CJB607_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 3 / 3 | GLN A 91HIS A 95ARG A 239 | HEM A 605 (-3.4A)SCN A1502 ( 4.8A)HEM A 605 (-4.7A) | 0.30A | 4qyqB-2gjmA:58.9 | 4qyqB-2gjmA:95.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QYQ_C_3CJC607_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 6 / 6 | GLN A 91ASP A 94HIS A 95ARG A 239GLU A 242ARG A 333 | HEM A 605 (-3.4A)HEM A 605 (-2.0A)SCN A1502 ( 4.8A)HEM A 605 (-4.7A)HEM A 605 ( 2.2A)HEM A 605 (-2.8A) | 0.56A | 4qyqC-2gjmA:27.2 | 4qyqC-2gjmA:95.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4QYQ_D_3CJD607_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 4 / 4 | GLN A 91HIS A 95ARG A 239GLU A 242 | HEM A 605 (-3.4A)SCN A1502 ( 4.8A)HEM A 605 (-4.7A)HEM A 605 ( 2.2A) | 0.53A | 4qyqD-2gjmA:22.2 | 4qyqD-2gjmA:95.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R29_C_SAMC301_0 (UNCHARACTERIZEDPROTEIN) |
3tjq | SERINE PROTEASEHTRA1 (Homosapiens) | 5 / 12 | ALA A 134ARG A 137GLY A 55ALA A 113GLY A 86 | SCN A 163 (-3.3A)SCN A 163 ( 4.4A)SCN A 163 ( 4.4A)SCN A 159 ( 4.6A)SCN A 159 ( 3.8A) | 1.28A | 4r29C-3tjqA:undetectable | 4r29C-3tjqA:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R29_C_SAMC301_0 (UNCHARACTERIZEDPROTEIN) |
3tl2 | MALATE DEHYDROGENASE (Bacillusanthracis) | 5 / 12 | ARG A 87ALA A 86GLY A 84ALA A 129MET A 130 | NoneNoneNoneSCN A 314 ( 4.0A)None | 1.26A | 4r29C-3tl2A:undetectable | 4r29C-3tl2A:21.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R38_C_RBFC201_2 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) |
5buo | AMYLOID BETA A4PROTEIN (Homosapiens) | 5 / 9 | ILE A 451LEU A 390VAL A 461ILE A 462PHE A 437 | SCN A 714 ( 3.9A)NoneGOL A 709 ( 4.9A)NoneNone | 1.23A | 4r38C-5buoA:undetectable | 4r38C-5buoA:17.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RDX_A_HISA502_0 (HISTIDINE--TRNALIGASE) |
5ohs | - (-) | 4 / 7 | GLU A 580ARG A 632GLY A 630GLY A 615 | NoneNoneSCN A 702 ( 4.3A)SCN A 702 ( 3.8A) | 0.90A | 4rdxA-5ohsA:undetectable | 4rdxA-5ohsA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4TWD_F_377F401_1 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
4l37 | ARYLPHORIN (Bombyxmori) | 4 / 7 | GLU B 375LEU B 256PHE B 411TYR B 249 | SCN B 708 (-3.8A)NoneNoneNone | 1.04A | 4twdF-4l37B:undetectable4twdJ-4l37B:undetectable | 4twdF-4l37B:16.574twdJ-4l37B:16.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4TWD_F_377F401_1 (CYS-LOOPLIGAND-GATED IONCHANNEL) |
4l37 | SILKWORM STORAGEPROTEIN (Bombyxmori) | 4 / 7 | GLU A 372LEU A 253PHE A 408TYR A 246 | SCN A 709 (-3.8A)NoneNoneNone | 1.03A | 4twdF-4l37A:undetectable4twdJ-4l37A:undetectable | 4twdF-4l37A:17.244twdJ-4l37A:17.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EKX_A_SAMA301_0 (NS5METHYLTRANSFERASE) |
4a6u | OMEGA TRANSAMINASE (Chromobacteriumviolaceum) | 5 / 12 | SER A 291GLY A 293GLY A 120GLY A 298GLY A 289 | NoneSCN A 602 ( 4.8A)NoneNoneNone | 0.96A | 5ekxA-4a6uA:undetectable | 5ekxA-4a6uA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FF1_A_MMZA601_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 5 / 5 | GLN A 91HIS A 95ARG A 239GLU A 242LEU A 246 | HEM A 605 (-3.4A)SCN A1502 ( 4.8A)HEM A 605 (-4.7A)HEM A 605 ( 2.2A)None | 0.39A | 5ff1A-2gjmA:59.5 | 5ff1A-2gjmA:95.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FF1_A_MMZA602_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 5 / 5 | GLN A 91HIS A 95ARG A 239GLU A 242LEU A 246 | HEM A 605 (-3.4A)SCN A1502 ( 4.8A)HEM A 605 (-4.7A)HEM A 605 ( 2.2A)None | 0.39A | 5ff1A-2gjmA:59.5 | 5ff1A-2gjmA:95.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FF1_B_MMZB601_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 5 / 5 | GLN A 91HIS A 95ARG A 239GLU A 242LEU A 246 | HEM A 605 (-3.4A)SCN A1502 ( 4.8A)HEM A 605 (-4.7A)HEM A 605 ( 2.2A)None | 0.38A | 5ff1B-2gjmA:65.7 | 5ff1B-2gjmA:95.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5FF1_B_MMZB613_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 5 / 5 | GLN A 91HIS A 95ARG A 239GLU A 242LEU A 246 | HEM A 605 (-3.4A)SCN A1502 ( 4.8A)HEM A 605 (-4.7A)HEM A 605 ( 2.2A)None | 0.38A | 5ff1B-2gjmA:65.7 | 5ff1B-2gjmA:95.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HNW_B_TA1B902_1 (TUBULIN BETA-2BCHAIN) |
2wl1 | PYRIN (Homosapiens) | 5 / 12 | VAL A 587LEU A 709HIS A 739SER A 728THR A 707 | NoneNoneNoneNoneSCN A1778 ( 4.7A) | 1.05A | 5hnwB-2wl1A:undetectable | 5hnwB-2wl1A:17.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HNY_B_TA1B601_1 (TUBULIN BETA-2BCHAIN) |
2wl1 | PYRIN (Homosapiens) | 5 / 12 | VAL A 587LEU A 709HIS A 739SER A 728THR A 707 | NoneNoneNoneNoneSCN A1778 ( 4.7A) | 1.10A | 5hnyB-2wl1A:undetectable | 5hnyB-2wl1A:18.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HNZ_B_TA1B902_1 (TUBULIN BETA-2BCHAIN) |
2wl1 | PYRIN (Homosapiens) | 5 / 12 | VAL A 587LEU A 709HIS A 739SER A 728THR A 707 | NoneNoneNoneNoneSCN A1778 ( 4.7A) | 1.09A | 5hnzB-2wl1A:undetectable | 5hnzB-2wl1A:17.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HPW_A_3CJA609_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 5 / 5 | GLN A 91HIS A 95ARG A 239GLU A 242ARG A 333 | HEM A 605 (-3.4A)SCN A1502 ( 4.8A)HEM A 605 (-4.7A)HEM A 605 ( 2.2A)HEM A 605 (-2.8A) | 0.43A | 5hpwA-2gjmA:59.2 | 5hpwA-2gjmA:95.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HPW_B_3CJB609_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 4 / 4 | GLN A 91HIS A 95ARG A 239ARG A 333 | HEM A 605 (-3.4A)SCN A1502 ( 4.8A)HEM A 605 (-4.7A)HEM A 605 (-2.8A) | 0.38A | 5hpwB-2gjmA:59.0 | 5hpwB-2gjmA:95.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HPW_B_3CJB609_1 (LACTOPEROXIDASE) |
5k9h | 0940_GH29 (unidentified) | 4 / 4 | GLN A 18HIS A 401ARG A 402ARG A 68 | NoneNoneGOL A 606 (-3.3A)SCN A 624 ( 3.6A) | 1.26A | 5hpwB-5k9hA:0.0 | 5hpwB-5k9hA:21.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HPW_C_3CJC609_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 6 / 6 | GLN A 91ASP A 94HIS A 95ARG A 239GLU A 242ARG A 333 | HEM A 605 (-3.4A)HEM A 605 (-2.0A)SCN A1502 ( 4.8A)HEM A 605 (-4.7A)HEM A 605 ( 2.2A)HEM A 605 (-2.8A) | 0.56A | 5hpwC-2gjmA:27.2 | 5hpwC-2gjmA:95.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HPW_D_3CJD609_1 (LACTOPEROXIDASE) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 4 / 4 | GLN A 91HIS A 95ARG A 239GLU A 242 | HEM A 605 (-3.4A)SCN A1502 ( 4.8A)HEM A 605 (-4.7A)HEM A 605 ( 2.2A) | 0.53A | 5hpwD-2gjmA:22.1 | 5hpwD-2gjmA:95.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IEN_A_VDYA201_2 (CDL2.2) |
4eb0 | LCC (unculturedbacterium) | 5 / 12 | ILE A 89LEU A 109GLY A 42PRO A 43LEU A 142 | NoneNoneSCN A 301 (-3.6A)NoneNone | 1.20A | 5ienA-4eb0A:undetectable | 5ienA-4eb0A:18.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KKZ_O_ASCO1004_0 (CYTOCHROME BUBIQUINOL-CYTOCHROMEC REDUCTASEIRON-SULFUR SUBUNIT) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 4 / 7 | HIS A 95ILE A 92VAL A 93TYR A 296 | SCN A1502 ( 4.8A)NoneNoneNone | 1.24A | 5kkzM-2gjmA:undetectable5kkzO-2gjmA:undetectable | 5kkzM-2gjmA:15.165kkzO-2gjmA:22.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LRB_A_ACRA1003_1 (ALPHA-1,4 GLUCANPHOSPHORYLASE) |
4l37 | ARYLPHORIN (Bombyxmori) | 4 / 6 | PHE B 401THR B 404TYR B 402TYR B 415 | NoneNoneSCN B 708 (-4.8A)None | 1.30A | 5lrbA-4l37B:undetectable | 5lrbA-4l37B:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LRB_A_ACRA1003_1 (ALPHA-1,4 GLUCANPHOSPHORYLASE) |
4l37 | SILKWORM STORAGEPROTEIN (Bombyxmori) | 4 / 6 | PHE A 398THR A 401TYR A 399TYR A 412 | NoneNoneSCN A 709 (-4.6A)None | 1.29A | 5lrbA-4l37A:undetectable | 5lrbA-4l37A:21.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NEK_B_AZMB302_1 (PEPTIDOGLYCANN-ACETYLGLUCOSAMINEDEACETYLASE) |
5bu6 | BPSB (PGAB),POLY-BETA-1,6-N-ACETYL-D-GLUCOSAMINEN-DEACETYLASE (Bordetellabronchiseptica) | 5 / 8 | ASP A 113ASP A 114HIS A 184HIS A 189PRO A 251 | None NI A 401 (-2.5A) NI A 401 ( 3.3A) NI A 401 ( 3.3A)SCN A 404 ( 4.7A) | 0.48A | 5nekB-5bu6A:9.3 | 5nekB-5bu6A:12.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NNW_D_GCSD302_1 (25 KDA PROTEINELICITOR) |
2gjm | LACTOPEROXIDASE (Bubalusbubalis) | 4 / 7 | GLY A 335HIS A 336HIS A 95ASP A 94 | HEM A 605 (-3.4A)HEM A 605 (-3.3A)SCN A1502 ( 4.8A)HEM A 605 (-2.0A) | 1.07A | 5nnwD-2gjmA:undetectable | 5nnwD-2gjmA:11.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5O96_B_SAMB501_0 (RIBOSOMAL RNA SMALLSUBUNITMETHYLTRANSFERASE E) |
2uye | REGULATORY PROTEIN (Burkholderiacepacia) | 5 / 9 | LEU A 213ILE A 218GLY A 217LEU A 268ALA A 266 | SCN A1306 ( 4.9A)NoneNoneSCN A1306 ( 4.5A)SCN A1306 ( 4.1A) | 0.93A | 5o96A-2uyeA:undetectable5o96B-2uyeA:undetectable | 5o96A-2uyeA:20.515o96B-2uyeA:20.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5OGC_B_TA1B601_1 (TUBULIN BETA CHAIN) |
2wl1 | PYRIN (Homosapiens) | 5 / 12 | VAL A 587LEU A 709HIS A 739SER A 728THR A 707 | NoneNoneNoneNoneSCN A1778 ( 4.7A) | 1.11A | 5ogcB-2wl1A:undetectable | 5ogcB-2wl1A:17.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UIH_A_8CVA201_1 (DIHYDROFOLATEREDUCTASE) |
3pvz | UDP-N-ACETYLGLUCOSAMINE 4,6-DEHYDRATASE (Aliivibriofischeri) | 4 / 8 | ILE A 270ALA A 201LEU A 5ILE A 265 | NoneSCN A 604 ( 4.9A)NoneNone | 0.71A | 5uihA-3pvzA:undetectable | 5uihA-3pvzA:15.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UUN_B_ACTB309_0 (GLUTATHIONES-TRANSFERASE-LIKEPROTEIN) |
4l37 | SILKWORM STORAGEPROTEIN (Bombyxmori) | 3 / 3 | TYR A 126ALA A 217TYR A 221 | NoneSCN A 711 ( 4.4A)None | 0.81A | 5uunB-4l37A:undetectable | 5uunB-4l37A:18.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V0V_A_8QPA612_1 (SERUM ALBUMIN) |
5aqa | OFF7_DB04V3 (syntheticconstruct) | 5 / 12 | LEU A 181LEU A 324LEU A 320ALA A 362GLU A 342 | NoneNoneNoneNoneSCN A1422 (-4.3A) | 1.18A | 5v0vA-5aqaA:undetectable | 5v0vA-5aqaA:21.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X2T_I_PEMI202_1 (HEMOGLOBIN SUBUNITALPHAHEMOGLOBIN SUBUNITBETA) |
4pcg | VP1 (Humanpolyomavirus6) | 4 / 8 | ALA A 185THR A 77THR A 246ALA A 40 | SCN A 301 (-3.5A)SCN A 301 ( 4.2A)NoneSCN A 303 (-4.9A) | 0.95A | 5x2tI-4pcgA:undetectable5x2tJ-4pcgA:undetectable5x2tK-4pcgA:undetectable5x2tL-4pcgA:undetectable | 5x2tI-4pcgA:19.485x2tJ-4pcgA:20.685x2tK-4pcgA:19.485x2tL-4pcgA:20.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Z84_J_CHDJ101_0 (CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) |
6d2v | TERB OXIDOREDUCTASE (Streptomyces) | 3 / 3 | TYR A 64ARG A 100THR A 103 | NoneNoneSCN A 402 ( 4.1A) | 1.03A | 5z84J-6d2vA:undetectable | 5z84J-6d2vA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZW4_A_SAMA302_1 (PUTATIVEO-METHYLTRANSFERASEYRRM) |
5dlb | CHAPERONE ESPG3 (Mycobacteriummarinum) | 4 / 6 | SER A 257GLU A 215ARG A 87ASP A 85 | SCN A 314 ( 2.9A)NoneNoneNone | 1.24A | 5zw4A-5dlbA:undetectable | 5zw4A-5dlbA:18.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6C71_B_NCTB501_1 (AMINE OXIDASE) |
3hk0 | GROWTH FACTORRECEPTOR-BOUNDPROTEIN 10 (Homosapiens) | 4 / 8 | LEU A 345TYR A 341GLU A 170ASN A 285 | SCN A 15 ( 4.8A)NoneNoneNone | 1.09A | 6c71B-3hk0A:undetectable | 6c71B-3hk0A:13.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EW0_B_TA1B501_2 (TUBULIN BETA CHAIN) |
5k9h | 0940_GH29 (unidentified) | 4 / 5 | LEU A 373THR A 344ARG A 403ARG A 356 | NoneNoneNoneSCN A 626 (-3.2A) | 1.20A | 6ew0B-5k9hA:undetectable | 6ew0B-5k9hA:9.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EW0_D_TA1D501_2 (TUBULIN BETA CHAIN) |
5k9h | 0940_GH29 (unidentified) | 4 / 5 | LEU A 373THR A 344ARG A 403ARG A 356 | NoneNoneNoneSCN A 626 (-3.2A) | 1.20A | 6ew0D-5k9hA:undetectable | 6ew0D-5k9hA:9.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EW0_H_TA1H501_2 (TUBULIN BETA CHAIN) |
5k9h | 0940_GH29 (unidentified) | 4 / 5 | LEU A 373THR A 344ARG A 403ARG A 356 | NoneNoneNoneSCN A 626 (-3.2A) | 1.20A | 6ew0H-5k9hA:undetectable | 6ew0H-5k9hA:9.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EW0_I_TA1I501_2 (TUBULIN BETA CHAIN) |
5k9h | 0940_GH29 (unidentified) | 4 / 5 | LEU A 373THR A 344ARG A 403ARG A 356 | NoneNoneNoneSCN A 626 (-3.2A) | 1.20A | 6ew0I-5k9hA:undetectable | 6ew0I-5k9hA:9.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6N7F_A_RBFA502_0 (PUTATIVE GLUTATHIONEREDUCTASE (GR)) |
4a6u | OMEGA TRANSAMINASE (Chromobacteriumviolaceum) | 4 / 7 | GLY A 293TYR A 294GLU A 40GLY A 67 | SCN A 602 ( 4.8A)NoneNoneSCN A 601 (-3.5A) | 0.88A | 6n7fA-4a6uA:undetectable | 6n7fA-4a6uA:10.96 |